Pitching her re-election to shareholders at REA’s AGM on Thursday, Kelly Bayer Rosmarin said she brought specific skills to the digital real estate behemoth’s board. Her “diverse experience” has given ...

Bayer Aktiengesellschaft remains deeply undervalued despite ongoing business struggles and litigation headwinds, with significant upside potential if challenges are resolved. Bayer's Q2 '25 results ...

Matt Nelson is an automotive journalist with nearly a decade of experience in all things cars. He's spent years working at dealerships in sales, finance, and service. He's since traded in his pens and ...

Bayer’s consumer health unit has named Interpublic Group as its creative, production and media partner, integrating the work at a single agency to boost its buying power and leverage generative AI.

BASEL, Switzerland--(BUSINESS WIRE)--The Consumer Health division of Bayer has selected Interpublic Group (NYSE: IPG) as the global agency partner for all creative, production and media, responsible ...

ST. PAUL, Minn., Sept. 10 (UPI) --German pharma giant Bayer this week published the full results of a major clinical study demonstrating the long-term safety and efficacy of its hot flash drug ...

Bayer announced July 30 that it has submitted applications in four major agricultural markets—the European Union, Brazil, Canada, and the United States—for a new herbicide with a new mode of action, ...

Bayer BAYN-2.50%decrease; red down pointing triangle said it would commercialize and complete research into a new potential cancer drug developed by U.S. biotech company Kumquat Biosciences. Under the ...

Bayer has teamed up with Kumquat Biosciences for a juicy opportunity, committing up to $1.3 billion for the global license to a KRAS G12D inhibitor that is on the cusp of the clinic. Kumquat, which ...

Bayer’s Roundup pesticide is linked with cancer. Its multi-million dollar fight to evade justice and accountability threatens to leave sick people holding the bag. Bayer’s Roundup pesticide is linked ...

A Bayer AG sign is seen in December 2024, at Bayer Crop Science in Chesterfield. Bayer has recently settled thousands of cases against the company over claims the active ingredient in its popular ...